Important Research-Use Disclaimer All peptides referenced in this guide including GLP-3 RT, AOD-9604, Tesamorelin, and CJC-1295/Ipamorelin are chemical reagents intended strictly for laboratory research purposes and are not for human use
Additionally, GLP-1 regulates insulin secretion from pancreas -cells in both normal and disease conditions [27]
Lilly is also running two other trials with eloralintide plus tirzepatide, including another mid-stage study in obese and overweight type 2 diabetes patients, with an initial completion date in June 2026, and a Phase I trial in nondiabetic individuals, scheduled to complete in October 2025
Quanta Magazine
Highlight potential out-of-pocket costs and explore manufacturer savings programs to maintain accessibility
One of the reasons patients choose Better Med Spa for peptide therapy over online telehealth scripts is that we can actually build a coordinated protocol